EVA
RAMOS ALONSO
Profesora titular de universidad
Francisco
López Muñoz
Publicaciones en las que colabora con Francisco López Muñoz (19)
2023
-
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics
Antioxidants, Vol. 12, Núm. 2
-
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging
Antioxidants, Vol. 12, Núm. 10
-
POTENTIAL OF MELATONIN TO REVERSE EPIGENETIC ABERRATIONS IN ORAL CANCER: NEW FINDINGS
EXCLI Journal, Vol. 22, pp. 1280-1310
-
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4
Antioxidants, Vol. 12, Núm. 9
-
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
Pharmaceutics, Vol. 15, Núm. 6
2022
-
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500
2021
-
The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy
Antioxidants, Vol. 10, Núm. 7
-
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
DISEASES, Vol. 9, Núm. 2
2020
-
Cerebral ischemia and traumatic brain injury: Protection by melatonin
Melatonin: Production, Functions and Benefits (Nova Science Publishers, Inc.), pp. 231-255
-
In Vitro and in Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases
ACS Chemical Neuroscience, Vol. 11, Núm. 22, pp. 3793-3801
-
Melatonin reduces NLRP3 inflammasome activation by increasing α7 nAChR-mediated autophagic flux
Antioxidants, Vol. 9, Núm. 12, pp. 1-18
-
Melatonin's efficacy in stroke patients; a matter of dose? A systematic review
Toxicology and Applied Pharmacology, Vol. 392
2019
-
Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics
Cancers, Vol. 11, Núm. 11
2018
-
In silico assessment of the metabolism and its safety significance of multitarget propargylamine ASS234
CNS Neuroscience and Therapeutics
-
Melatonin: A hypothesis for Kawasaki disease treatment
Medical Hypotheses, Vol. 119, pp. 6-10
-
Modulation of Heat Shock Response Proteins by ASS234, Targeted for Neurodegenerative Diseases Therapy
Chemical Research in Toxicology, Vol. 31, Núm. 9, pp. 839-842
-
Neuroinflammation Signaling Modulated by ASS234, a Multitarget Small Molecule for Alzheimer's Disease Therapy
ACS Chemical Neuroscience, Vol. 9, Núm. 12, pp. 2880-2885
2017
2016
-
Melatonin and nitrones as potential therapeutic agents for stroke
Frontiers in Aging Neuroscience, Vol. 8, Núm. NOV